Great Leadership By Dan

JUNE 14, 2018

When does pharmaceutical pricing become price gouging? Employees and managers in the autonomy stage are ready for mature leadership. Those in the ideological stage may have charisma but are best avoided when top leadership responsibilities are assigned. They require careful analysis, not gut feeling or simplistic platitudes.

Ethics 197

Ethics Maturity Analysis Cost-Benefit Analysis 197

Michael Lee Stallard

SEPTEMBER 16, 2015

Pfizer, the multinational pharmaceutical giant, has become increasingly intentional about shaping its culture. Leading a global business means managing operations in some nations where meeting high ethical standards is more challenging given the prevalence of corruption in the local culture.

Ethics 150

Ethics Pharmaceuticals Globalization Commitment 150

Tanveer Naseer

AUGUST 2, 2016

These conversations with my daughter about her work has lead to recollections of my summer job experiences, and how one in particular has helped to shape my understandings of leadership and empowering employees.

Pharmaceuticals 100

Pharmaceuticals Loyalty Learning-by-Doing Project 100

Lead Change Blog

JULY 6, 2015

This singular emphasis on results can, however, cause players to operate from an “I win, you lose” philosophy – and act to inhibit others’ performance while they maximize their own. If the only things that leaders demand are results and performance, players in your organization will do their best to deliver those things.

Pharmaceuticals 150

Pharmaceuticals Discount Cooper Tactics 150

Chartered Management Institute

FEBRUARY 26, 2024

This premise equally applies to the environment businesses operate in today. Human error is a very real consequence of people operating in the real world. Since founding the Human Diver in 2016, Gareth has given risk training to a wide variety of organisations, from oil and gas and construction to pharmaceuticals and software.

Uncertainty 52

Uncertainty Risk Management Training Learning-by-Doing 52

HR Digest

NOVEMBER 10, 2021

Having joined the world’s largest pharmaceutical company, she is now out to raise the bar for human resources leadership across the organization. The HR Digest: Under your leadership, Pfizer continues to make great strides in the field of diversity and inclusion (D&I). The HR Digest: What is diversity to you?

Diversity 102

Diversity Commitment Learning-by-Doing Globalization 102

Harvard Business Review

MARCH 21, 2018

These kinds of statements speak to a leader’s choice of values, and a failure to understand the relationships between a safe work environment and operational performance. The reality is that virtually all workplace injuries are preventable, and safety management and operational excellence are intimately linked. At Cummins, Inc.,

Operations 18

Operations Chemicals CEO Metrics 18

Strategy Driven

APRIL 3, 2014

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 51

Tactics Execution Pharmaceuticals Human Capital 51

The Horizons Tracker

FEBRUARY 22, 2022

billion and is estimated to be worth $48 billion by 2026, with the Covid pandemic driving growth, especially in the healthcare and pharmaceutical industries, but also in sectors such as automotive and defense. It’s a market that is already worth $3.1 “With 5G, you get fast upload speeds, up to 100Gbsp on many public networks.

Stephenson 109

Stephenson Wireless Christensen Automotive 109

Marshall Goldsmith

NOVEMBER 4, 2013

The changing role of leadership will mean that the relationship between managers and direct reports will have to change in both directions. Many leaders will be operating more like the managing director of a consulting firm. The same trend is occurring in pharmaceuticals and telecommunications. Employee Engagement Leadership'

Short-term 107

Short-term Long-term Trends Telecommunications 107

Strategy Driven

JULY 13, 2011

Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

OCTOBER 6, 2016

Investments in traditional leadership development are often misguided and a waste of money. In a Deloitte study of 7,000 organizations this year, 89% of executives rated “ strengthening the leadership pipeline ” an urgent issue. Paul Garbett for HBR. It’s not that development itself isn’t important.

Leadership Pipeline 13

Leadership Pipeline Leadership After Action Review Pharmaceuticals 13

Harvard Business Review

JULY 23, 2015

For years, there has been a push within the pharmaceutical industry to move “beyond the pill” — in other words, to build and deploy complementary services and solutions to diversify revenue sources. However, many beyond-the-pill efforts have sputtered or died. In addition, many top pharma customers (payers, etc.)

Pharmaceuticals 8

Pharmaceuticals Health Care Industry Committee 8

Harvard Business Review

JUNE 23, 2016

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. That, in brief, is the concept of a leadership circle. While a natural inclination, this group is (by design) representative of current operating units and functions, which often have a status quo to defend.

Leadership 10

Leadership Diversity Committee Long-term 10

Harvard Business Review

NOVEMBER 15, 2018

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. Cost reduction requires an honest and thorough reassessment of everything the health system does and ultimately, a change in the organization’s operating culture. PM Images/Getty Images. ” Clearly, more is needed.

Cost 11

Cost System Management Franchising 11

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. My senior executives and I made our values the language of leadership. This must come from the top.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

NOVEMBER 29, 2018

In this article, I’d like to share the insights we’ve gleaned from the model’s first full year of operation, which hopefully organizations in health care and many other industries will find useful. The reporting lets executive leadership know precisely what is happening and unlocks frontline wisdom.

Health Care 11

Health Care System Metrics Report 11

Harvard Business Review

APRIL 7, 2015

Having managed or worked with clinical leaders in care-delivery organizations, the pharmaceutical industry, and government, I have observed three skills that are critical to the success of doctors and nurses as they make the transition to management: Operations management and execution. People leadership.

Execution 8

Execution Skills Health Care Porter 8

Harvard Business Review

AUGUST 8, 2018

But how well schools meet this goal, and to what extent their teaching influences their students’ leadership, is an open question. As chief executive, Dolan followed the agency-theoretic prescription that was taught in business schools in the late 1970s, refocusing his company’s business almost exclusively on pharmaceuticals.

Influence 13

Influence Education Pharmaceuticals Finance 13

Harvard Business Review

JANUARY 15, 2017

We also discovered a staggering lack of confidence in leadership: 71% of survey respondents said government officials are not at all or somewhat credible, and 63% said the same about CEOs. For example, 82% of respondents said that the pharmaceutical industry needs greater regulation. Related Video.

Survey 12

Survey Media Globalization Pharmaceuticals 12

Strategy Driven

JANUARY 24, 2011

Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. Many innovative ideas became the victims of in-fighting among managers who had competing objectives.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

JANUARY 22, 2014

The first concerns a complex transatlantic acquisition of a biotech company by a pharmaceutical company. There were major overlaps in corporate and operational management positions, but most employees would be retained. And, judging from employee surveys, most managers rose to the leadership challenge.

Pharmaceuticals 8

Pharmaceuticals Uncertainty How To Middle Management 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

NOVEMBER 9, 2011

COOs are relatively common in service industries such as financial services, energy, information technology and telecommunications, but in manufacturing sectors — such as automotive, chemical, and pharmaceutical companies — they are relatively rare. What do you think?

COO 14

COO Sample Telecommunications Automotive 14

Harvard Business Review

MARCH 16, 2015

Their concerns fell into three broad categories: talent, operating in a global marketplace, and regulation and legislation. Operating in a Global Marketplace. Eight of the CEOs pointed to the challenges of operating in a fast-paced global marketplace. As a pharmaceutical company, we obviously were part of that whole ecosystem.

CEO 8

CEO Stephenson Pharmaceuticals Globalization 8

Harvard Business Review

MARCH 2, 2012

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. economy, expands America's global trade, and attracts foreign companies to base operations in the U.S. Visa restrictions also limit U.S.

Competitive Advantage 15

Competitive Advantage Globalization Development Intellectual Capital 15

Harvard Business Review

JULY 28, 2015

Let’s look at a few examples of powerful summaries: “Pharmaceutical marketing executive with 20 years of experience creating commercial infrastructures, growing brands, and optimizing product value throughout launch, re-launch, and sunset life cycles across all customer segments—payers, physicians, and patients.

Pharmaceuticals 8

Pharmaceuticals Retail Long-term Industry 8

Harvard Business Review

NOVEMBER 27, 2015

One notable critic, Warren Bennis, a renowned leadership scholar from the University of Southern California, states that business schools have “an overemphasis on the rigor and an underemphasis on relevance.” Business schools responded. Now, years later, educators have been criticized for going too far.

Company 8

Company Education Pharmaceuticals Project 8

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. When innovations don't fit neatly into the slots that already exist, innovators must operate by stealth, going around the establishment.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JUNE 20, 2017

Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency. Prasad, CEO of Dr. Reddy’s, a 33-year-old global pharmaceutical company headquartered in India that produces affordable generic medication.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

JUNE 22, 2016

For example, do you make and sell things, hire skilled employees and provide services, develop and new IP like software or pharmaceuticals, or build and manage digital networks, be they transactional, informational, or social? Organizational transformation must begin with a leadership transformation.

Intangible Assets 10

Intangible Assets Business Model How To Intellectual Capital 10

Harvard Business Review

NOVEMBER 10, 2017

Spending on corporate learning, particularly leadership development, continues to increase at a staggering pace. According to one piece of research , spending on frontline leadership development alone increased by over 310% in a three-year period. Pat Canova/Getty Images. Insight center. The Gap Between Strategy and Execution.

Skills 11

Skills Agility Learning-by-Doing Content 11

Strategy Driven

MARCH 18, 2011

Those companies that ‘sweat’ their capabilities continuously improve them and sustainably capture the top-line growth in their industries and, ultimately, market leadership. Companies today operate in a business environment that encourages incoherence. Second, a coherent system focuses strategic investment on what matters.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

JULY 7, 2011

Many of the best leaders and managers in the business world operate from the Pleaser power style. When they are operating from their strengths, Pleasers can become the glue that holds a positive corporate culture together. Roger, a vice president of sales and marketing in the pharmaceutical industry, was one such Pleaser.

Rogers 15

Rogers Morale Long-term Pharmaceuticals 15

Harvard Business Review

JULY 6, 2017

The executives came from a wide array of industries, including financial services, pharmaceuticals, and media. They were more likely to operate based on black-and-white ideals, such as, “There is one best idea that should prevail” or “I am running a pure meritocracy.”

Execution 14

Execution 360-Degree Feedback Executive Coaching Sample 14

Harvard Business Review

SEPTEMBER 19, 2016

Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. It is a simple, clear, and highly useful criterion — for routine decisions in businesses operating in competitive markets and with sound legal systems. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8